Notch Therapeutics is a Vancouver cell therapy company developing off-the-shelf T cell therapies from induced pluripotent stem cells. Its platform is built around controlled T cell differentiation and engineered manufacturing processes designed to produce uniform, renewable cell therapy starting material. Public materials position the company around allogeneic immunotherapy and scalable next-generation CAR-T style development.